Skip to content
Screener

Opko Health OPK Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$1.06B+19.0%
Regenxbio logo
RegenxbioRGNX
$486K-26.8%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$41M+136%
PTH
Pelthos TherapeuticsPTHS
$31.96M
Exelixis logo
ExelixisEXEL
$122.62M-4.6%
ALN
Alnylam PharmaceuticalsALNY
$9.15M-16.3%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$1.02B-0.9%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemJune 30, 2026December 31, 2025
Long term portion of convertible notes89,85785,020
Senior secured royalty financing246,854246,433
Deferred tax liabilities108,230126,241
Other long-term liabilities16,99922,799
Total long-term liabilities495,920517,308
Total liabilities645,287663,985
Equity:
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 776,128,402 and 789,917,433 shares issued at June 30, 2026 and December 31, 2025, respectively7,7627,900

Item 1. Financial Statements

FAQ

What is Opko Health's other non-current liabilities?
Opko Health (OPK) reported other non-current liabilities of $17M in Q2 2026.
How has Opko Health's other non-current liabilities changed year-over-year?
Opko Health's other non-current liabilities decreased by 38.9% year-over-year, from $27.81M to $17M.
What is the long-term trend for Opko Health's other non-current liabilities?
Over 5 years (2020 to 2025), Opko Health's other non-current liabilities has grown at a -9.3% compound annual growth rate (CAGR), from $37.07M to $22.8M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Opko Health's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude